Understand the source comparison
Best Research Peptides for Rosacea: Mechanism Comparison
KPV NF-κB inhibition in mast cells Anti-inflammatory Preclinical + case reports Topical Strongest evidence for erythema reduction; requires permeation enhancer BPC-157 Vascular stabilization, endothelial repair Angiogenesis modulation Animal models only Subcut
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- KPV
- NF-κB inhibition in mast cells
- Anti-inflammatory
- Preclinical + case reports
- Topical
- Strongest evidence for erythema reduction; requires permeation enhancer
- BPC-157
- Vascular stabilization, endothelial repair
- Angiogenesis modulation
- Animal models only
- Subcutaneous or oral
- Promising for telangiectatic rosacea; no human trials yet
- LL-37 analogs
- Corrects aberrant cathelicidin processing
- Innate immunity
- Mechanistic studies
- Research-phase only
- Addresses root cause but no therapeutic products exist
- Thymosin β4
- ECM remodeling, cytokine modulation
- Wound healing / barrier repair
- Wound studies (not rosacea-specific)
- Topical or subcutaneous
- Relevant for papulopustular subtype; more research needed
- Melanotan II
- MC receptor activation, anti-inflammatory
- UV protection / immune modulation
- Photoprotection studies
- Subcutaneous
- Speculative for rosacea; insufficient data